|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/11 | (2006.01) |
| A61K 31/711 | (2006.01) | ||
| A61K 39/39 | (2006.01) |
| (11) | Patento numeris | 2650369 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13171674.8 |
| Europos patento paraiškos padavimo data | 2008-07-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-04-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 953251 P | 2007-08-01 | US | |
| 983601 P | 2007-10-30 | US | |
| 987151 P | 2007-11-12 | US | |
| 15292 P | 2007-12-20 | US |
| (72) |
Kandimalla, Ekambar R., US
Reddy Putta, Mallikarjuna, US
Wang, Daqing, US
Yu, Dong, US
Lakshmi, Bhagat, US
Agrawal, Sudhir, US
|
| (73) |
Idera Pharmaceuticals, Inc.,
167 Sidney Street, Cambridge, MA 02139,
US
|
| (54) | Novel synthetic agonists of TLR9 |
| Novel synthetic agonists of TLR9 |